[Skip to Navigation]
Article
April 1981

Coronavirus Antibodies in Sera From Patients With Multiple Sclerosis and Matched Controls

Author Affiliations

From the Infectious Diseases Branch, National Institute of Neurological and Communicative Disorders and Stroke (Drs Madden, Wallen, Houff, Leinikki, and Sever); the Department of Pathology, Uniformed Services University of the Health Sciences (Dr Holmes); and Microbiological Associates (Drs Castellano and Shekarchi), Bethesda, Md.

Arch Neurol. 1981;38(4):209-210. doi:10.1001/archneur.1981.00510040035004
Abstract

• Sera from patients with multiple sclerosis and carefully matched controls were tested for antibodies to three strains of coronavirus. There was no significant difference in the levels of antibody in the patients vs the controls. We conclude that unless the strains of coronaviruses recently reported to have been isolated from patients with multiple sclerosis express important serological differences from those used in these studies, coronaviruses are not associated with the cause of multiple sclerosis.

×